http://www.yaohaibiological.com/ CDMO service platform of microbial expression system Serving by heart, Co-creating the future Jiangsu Yaohai Bio-pharmaceutical Co., Ltd. Company Introduce锛?/strong> Jiangsu Yao Hai Bio-Pharmaceutical Co., Ltd established in August 2010, known as Jiangsu Neptunus Bio-Pharmaceutical Co., Ltd. It is located in Taizhou Pharmaceutical zone which is the first high-tech pharmaceutical of national- class in china. Our company is committed to providing the Contract-research & manufacturing of biological products services which built with open-minded, Omni-bearing and integrating attitude based on service platform. The platform includes CRO/CMO/MAH systems which improve feasible solutions efficiency for customers. The philosophy of us is "Serve by heart, co-create the future" Company Scope: Our construction occupied 8088 square meters built in accordance with the GMP requirements. A 50+500L microbial fermentation and purification with 1500 square meters production line. A 50+200+1000+2000L microbial fermentation and purification with production line of 1500 square meters. 1500 square meters鈥?workshop, quality control laboratories and research and development facilities of 1150 square meters. The company obtained the Pharmaceutical Production License in 2012. Also we have professional technical teams from Chinese academy of sciences, Chinese academy of agricultural sciences, Jiangsu University, Sichuan University and other institutions of higher learning and institutions which contains professional GMP workshops and supporting equipment to provide customers with professional and assured services. Service Content: Busines Model Expression System Service content Fermentation ScalePreparation condition CRO Bacillus coli and saccharomycesProvide small-scale test process development, pilot scale-up research, quality standard research, registration and application services10L銆?/strong>30L銆?/strong>50LPreparation production of polypeptide or antibody (Xilin bottle freeze-dried powder and water needle) Suitable specification:1ml-25ml Speed and capacity: Based the calculation of 2 ml vials the maximum production speed is 300 vials / min the maximum freeze-drying batch is 40000 CMOProvide pilot scale research, registered batch sample production and clinical sample production services50L+500L 50+200+1000+2000L MAHProvide entrusted production services for the listing of varieties in line with the policy of listing license holders50L+500L 50+200+1000+2000L Project CooperationCooperate with customers to cultivate varieties suitable for our company's platform production CRO Service锛歂ew drug technology development, new drug platform Setting up, registration and reporting services, and preparation of preclinical research samples CMO / MAH mode: to provide the service of pilot-scale production, process route optimization, product yield and quality improving; to carry out the industrial production under the reference of MAH policy Project Cooperation: co-develop new products CRO Platform: Platform profile: The platform takes the gene recombination medicine development .Use the service direction with the fastest speed helps customers to advance the project progress for the service objective. The scope of service mainly covers new drug process development, pre-clinical research sample preparation, registration and declaration services. New products on the ground incubation provides customers with an integrated open technical service platform. The company has a full range of high-precision equipment which can meet the needs of customers. ACQUITY Arc Bio systemUltiMate 3000GE AKTA pure 150 system CMO Platform: 500L Fermentation&Purification Platform: E. coli/yeast system, diversified varieties Fermentation experience with multiple expression modes (low / high density) Automatic fermentation system (50-500L ) PALL automatic hollow fiber ultrafiltration system Purification scale from small to large, personalized service Automatic chromatography system, industrial-grade automatic HPLC preparation system Diverse chromatographic separation system 锛圓ffinity column, gel filtration, ion exchange, hydrophobic chromatography, high performance liquid chromatography锛?/p> BIO-DVT3000 fermentation systemFermentation system Cooperation Partners: Contact Us: Phone Number锛?523-86202833 Business Director Name:Ruidong Zhu Mobile:15996011292 Business Development Manager Name锛歒azhou Wang Mobile: 17314779667 Business Development Manager Name: Kai Yuan Mobile: 15152616235 Company address锛歁edicine High-Tech Developmental Zone, Taizhou, Jiangsu, ChinaChina sampling swab with virus transport medium tube factory website:http://www.yaohaibiological.com/ website2:http://www.yaohai-bio8.com/

Bioreactors and Fermenters market Professional Survey Report by 2035 Bioreactors and fermenters play an indispensable role in the upstream biomanufacturing by providing requisite conditions for producing high-value products, including recombinant proteins, tissue engineered constructs and in vitro cell-based models Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Bioreactors and Fermenters Market, 2023-2035”. The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:  An executive summary of the insights captured during our research, offering a high-level view on the current state of the global bioreactors and fermenters market and its likely evolution in the mid-long term.  A general introduction to bioreactors and fermenters, along with details related to the components of a bioreactor. Additionally, the chapter presents information on different types of bioreactors based on type of bioprocess and mode of action. Further, it concludes with a discussion on applications of bioreactors and future perspectives in this domain.  A detailed assessment of the overall market landscape of companies manufacturing bioreactors and fermenters, based on several relevant parameters.  A detailed competitiveness analysis of bioreactor and fermenter manufacturers based on manufacturer strength and product portfolio strength.  Elaborate profiles of key players manufacturing bioreactors and fermenters (shortlisted based on their bioreactor and fermenter manufacturing capabilities).  An estimate of the global installed capacity of bioreactors and fermenters for biologics manufacturing, based on information provided by various industry stakeholders in the public domain.  A case study on the market landscape of bioprocess controllers and automation systems, providing information on several relevant parameters.  The financial opportunity within the global bioreactors and fermenters market has been analyzed across the following segments:  Type of Product  Bioreactors  Fermenters  Fabrication Material  Glass  Stainless Steel  Single-use  Type of Bioprocess  Batch and Fed-batch  Continuous  Type of Biologic  Antibodies  Vaccines  Cell Therapies  Other Biologics  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World Key companies covered in the report  Applikon Biotechnology  Bionet  Cytiva  Eppendorf  Merck  Ollital Technology  Parr Instrument Company  Sartorius  Shanghai Bailun Biological Technology  Solaris Biotech  Solida Biotech  Zhengzhou Laboao Instrument Equipment (LABAO) To view more details on this report, click on the link https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market Medical Device Coatings Market Smart Pharmaceutical and Healthcare Labels Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #bioreactorsandfermenters #bioreactorsandfermentersmarket #fermentation #fermentationbioreactors #bioreactorsandfermentersmarketsize

USA warehouse Cosmetic Peptide EGF secreted by each of us, when we were in child times the secretion is the highest, and then it decreased with age increases. Particularly, After 22 years of age, reduced secretion was more pronounced. When we use cosmetics containing EGF, absorbed through the skin, added EGF of our skin exogenously, so that it can make our skin to restore the young state. We use E.coli by genetic engineering expressed, produced high purity EGF by biological fermentation. It was named Recombinant human epidermal growth factor (rhEGF). rhEGF have same structure with Human epidermal growth factor (EGF), it is a 6.2kDa protein.EGF stimulates the proliferation and differentiation of epithelial cells from skin, the cornea, lung and tracheal tissue and the gastrointestinal tract. EGF also promotes the proliferation of fibroblasts and embryonic cells. Thus, EGF plays an important role in wound healing and organogenesis. egf powder is a highly efficient cell division factor with many other biological effects, which mainly includes: 1. stimulating the growth and proliferation of skin, cornea and tracheal epithelium tissue in vivo. 2. Accelerating the healing process of epidermis damage on skin, cornea, etc. 3. Repressing the gastric acid excretion. 4. Accelerating the proliferation of epithelial cells in human and animals. 5. Facilitating the biosynthesis of protein, RNA, DNA as well as metabolic activity in epidermal cells. Nameegf powder CAS No62253-63-8 GradecosmeticUSA warehouse Cosmetic Peptide website:http://www.hgh191aa.com/hgh-and-peptide/fitness-peptides/